Literature DB >> 16010180

Epoetin alfa once weekly improves anemia in HIV/hepatitis C virus-coinfected patients treated with interferon/ribavirin: a randomized controlled trial.

Mark S Sulkowski, Douglas T Dieterich, Edmund J Bini, Norbert Bräu, Daniel Alvarez, Edwin Dejesus, Gerhard J Leitz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16010180     DOI： 10.1097/01.qai.0000167158.90722.73

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  7 in total

Review 1.  Clinical recommendations for the use of recombinant human erythropoietin in patients with hepatitis C virus being treated with ribavirin.

Authors:  Morris Sherman; Lawrence Cohen; Mary Anne Cooper; Magdy Elkashab; Victor Feinman; David Fletcher; Nigel Girgrah; Jenny Heathcote; Mark Levstik; William B McNaull; David Wong; Florence Wong; Colina Yim
Journal:  Can J Gastroenterol       Date:  2006-07       Impact factor: 3.522

Review 2.  Management complexities of HIV/hepatitis C virus coinfection in the twenty-first century.

Authors:  Vincent Lo Re; Jay R Kostman; Valerianna K Amorosa
Journal:  Clin Liver Dis       Date:  2008-08       Impact factor: 6.126

Review 3.  Barriers to hepatitis C antiviral therapy in HIV/HCV co-infected patients in the United States: a review.

Authors:  Christine U Oramasionwu; Heather N Moore; Joshua C Toliver
Journal:  AIDS Patient Care STDS       Date:  2014-04-16       Impact factor: 5.078

4.  Management of chronic hepatitis C virus in patients with HIV.

Authors:  Stephanie A Santos; Nickolas Kontorinis; Douglas T Dieterich
Journal:  Curr Treat Options Gastroenterol       Date:  2005-12

Review 5.  Therapeutic issues in HIV/HCV-coinfected patients.

Authors:  M S Sulkowski; Y Benhamou
Journal:  J Viral Hepat       Date:  2007-06       Impact factor: 3.728

6.  Pegylated interferon 2a and 2b in combination with ribavirin for the treatment of chronic hepatitis C in HIV infected patients.

Authors:  Ravinder Dhillon; Simona Rossi; Steven K Herrine
Journal:  Ther Clin Risk Manag       Date:  2008-08       Impact factor: 2.423

7.  Low rates of sustained virologic response with peginterferon plus ribavirin for chronic hepatitis C virus infection in HIV infected patients in Rio de Janeiro, Brazil.

Authors:  Halime Silva Barcaui; Gerson Carreiro Tavares; Silvia Beatriz May; Carlos Eduardo Brandão-Mello; Márcia Maria Amendola Pires; Paulo Feijó Barroso
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.